User menu

Effect of Suloctidil On Rat-liver

Bibliographic reference Thinessempoux, D. ; Bovykesler, C. ; Debruyne, E. ; Roba, J.. Effect of Suloctidil On Rat-liver. In: Archives of Toxicology, Vol. 59, no. 2, p. 115-120 (1986)
Permanent URL
  1. Arai Y, Nishi H, Endo N (1983) Effect of suloctidil on rat liver microsomal drug-metabolizing enzymes. Iyakuhin Kenkyu 14: 930?937
  2. Bargheon J (1977) Evaluation de l'activité thérapeutique du suloctidil chez le vieillard atteint d'insuffisance cérébro-vasculaire ? Etude en double insu par comparaison à un placebo. Acta Clin Belg 32: 15?21
  3. Baudhuin P, Beaufay H, Rahman-Li Y, Sellinger OZ, Wattiaux R, Jacques P, de Duve C (1974) Tissue fractionation studies. 17. Intracellular distribution of monoamine oxidase, aspartate aminotransferase, alanine aminotransferase, D-amino acid oxidase and catalase in rat-liver tissue. Biochem J 92: 179?184
  4. Baudhuin P, Leroy-Houyet MA, Quintart J, Berthet P (1979) Application of cluster analysis for characterization of spatial distribution of particles by stereological methods. J Microsc 115: 1?17
  5. Beaufay H, Amar-Costesec A, Feytmans E, Thines-Sempoux D, Wibo M, Robbi M, Berthet J (1974) Analytical study of microsomes and isolated subcellular membranes from rat liver. I. Biochemical Methods. J Cell Biol 61: 188?200
  6. Beaujard E, Bon H, Gaillard F, Perrin D (1984) Hépatites dues au suloctidil. Presse, Méd 13: 1217?1218
  7. Beckett RB, Weiss R, Stitzel RE, Cenedella RJ (1972) Studies on the hepatomegaly caused by the hypolipidemic drugs nafenopin and clofibrate. Toxicol Appl Pharmacol 23: 42?53
  8. Benzi G, Arrigoni E, Dagani F, Marzatico F, Curti D, Manzini A, Villa RF (1979) Effect of chronic treatment with some drugs on the enzymatic activities of the rat brain. Biochem Pharmacol 28: 2703?2708
  9. Benzi G, Arrigoni E, Dagani F, Marzatico F, Curti D, Raimondo S, Dossena M, Polgatti M, Villa RF (1980) Age-dependent modification of drug interference on the enzymatic activities of the rat brain. Exp Geront 15: 593?603
  10. Capron MH, Cabrieres F, Lauga J (1984) Hépatites au suloctidil: une mise au point. Presse Méd 13: 2155
  11. Chatelain P, Reckinger N, Roncucci R (1979) Effect of suloctidil on Na+/K+ ATPase activity and on membrane fluidity in rat brain synaptosomes. Biochem Pharmacol 28: 3677?3680
  12. Chatelain P, Demol D, Roba J (1984) Inhibition by suloctidil of [3H] nitrendipine binding to cerebral cortex membranes. Biochem Pharmacol 33: 1099?1103
  13. Ciavarella N, Antoncecchi S, D'Elia N, Ettore C, Ranieri P, Manzini A (1983) Normalization by suloctidil of decreased platelet survival in patients with heart prosthetic valves in randomized controlled double blind trial. Eur Heart J 4, suppl. 1: 3
  14. Col-de Beys C, Ferrant A, Moriau M (1981) Effects of suloctidil on platelet survival time following cardiac valve replacement. Thromb Haemostas 46: 550?553
  15. Galeone F, Scalabrino A, Giuntoli F, Morini S, Guidi G, Birindelli A, Saba P (1982) Clinical investigation on activity of suloctidil (Locton) in hyperlipidemic patients. Curr Ther Res 32: 879?884
  16. Gent M, Blakely JA, Hachinski V, Roberts RS, Barnett HJM, Bayer NH, Carruthers SG, Collins SM, Gawel MG, Giroux-Klimek M, Hopkins MB, Jain P, Lamy M, Meloche JP, Saerens E, Sicurella J, Turpie AGG (1985) A secondary prevention, randomized trial of suloctidil in patients with a recent history of thromboembolic stroke. Stroke 16: 416?424
  17. Gillot P (1978) Long-term survey of suloctidil: efficacy and tolerance in chronic peripheral arteriopathy. Curr Ther Res 23: 724?729
  18. Hess R, Stäubli W, Reiss W (1965) Nature of the hepatomegalic effect produced by ethyl-chlorophenoxyisobutyrate in the rat. Nature 208: 856?858
  19. Itil TM, Mukherjee S, Michael ST, Dayican G, Shapiro DM, Kunitz A, Saerens E (1983) Clinical and electrophysiological effects of suloctidil in elderly patients with multi-infarct dementia (A double-blind, placebo-controlled study). Psychopharmacol Bull 19: 730?733
  20. Jones NAG, de Haas H, Zahavi J, Kakkar VV (1982) A double-blind trial of suloctidil versus placebo in intermittent claudication. Br J Surg 69: 38?40
  21. Keeping ES (1962) Introduction to statistical inference, D. Van Nostrand Company Inc., Princeton N.J.
  22. Lazarow PB (1977) Three hypolipidemic drugs increase hepatic palmitoyl-coenzyme A oxidation in the rat. Science 197: 580?581
  23. Lazarow PB, de Duve C (1976) A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug. Proc Natl Acad Sci USA 73: 2043?2046
  24. Lazarow PB, Shio H, Leroy-Houyet MA (1982) Specificity in the action of hypolipidemic drugs: increase of peroxisomal ?-oxidation largely dissociated from hepatomegaly and peroxisome proliferation in the rat J Lipid Res 23: 317?326
  25. Leighton F, Coloma L, Koenig C (1975) Structure, composition, physical properties and turnover of proliferated peroxisomes. A study of the trophic effects of Su-13437 on rat liver. J Cell Biol 67: 281?309
  26. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ (1951) Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265?275
  27. Moody DE, Reddy JK (1978) The hepatic effects of hypolipidemic drugs (clofibrate, nafenopin, tibric acid and Wy-14,643) on hepatic peroxisomes and peroxisome-associated enzymes Am J Pathol 90: 435?437
  28. Moriau M, Col-de Beys C, Pardonge E, Ferrant A (1982) Clinical and biological activity of the antiplatelet agent suloctidil in treatment of idiopathic recurrent vein thrombosis (I. R. V. T.). Thromb Haemostas 47: 27?31
  29. Peeters H, Blaton V, Declercq B, Vandamme D, Roba J, Roncucci R, Lambelin G (1977) Effects of suloctidil on lipid metabolism in experimental animals. Arzneim Forsch 27: 1964?1967
  30. Reedy JK, Azarnoff DL, Svoboda DJ, Prasad JD (1974) Nafenopin induced hepatic microbody (peroxisome) proliferation and catalase synthesis in rats and mice. J Cell Biol 61: 344?358
  31. Reddy JK, Azarnoff DL, Hignite CE (1980) Hypolipidaemic hepatic peroxisome proliferators for a novel class of chemical carcinogens. Nature 283: 397?398
  32. Reddy JK, Krishnakantha TP (1975) Hepatic peroxisome proliferation: Induction by two novel compounds structurally unrelated to clofibrate. Science 190: 787?789
  33. Roba J, Catillon H, Roncucci R, Lambelin G, Gérin G, Lansen J, Rosseneu M, Blaton V (1979) Anti-dyslipemic effect of suloctidil in rhesus monkeys under atherogenic diet. Thromb Haemostas 42: 473
  34. Roba J, Defreyn G, Biagi G (1983) Antithrombotic activity of suloctidil. Thromb Res suppl. 4: 53?58
  35. Roba J., Roncucci R., Lambelin G., Pharmacological Properties of Suloctidil, 10.1080/17843286.1977.11717831
  36. Roncucci R, Roba J, Lambelin G, Ferenczi M, Blaton V, Vandamme D, Peteers H (1975) Potential antilipolytic activity of suloctidil. Naturwissenschaften 62: 141?142
  37. Schouten JA, Westerman RF (1982) Elevated liver enzymes in serum during suloctidil treatment. Eur J Clin Pharmacol 22: 559?560
  38. Svoboda D, Grady H, Azarnoff D (1967) Microbodies in experimentally altered cells. J Cell Biol 35: 127?152
  39. Tokiwa T, Miyoshi K, Takahashi T, Nomura A, Fujii O (1984) Toxicological studies on suloctidil. III. Chronic toxicity study in beagle dogs. Iyakuhin Kenkyu 15: 35?62
  40. Turpie AGG, Gent M, Deboer AC, Giroux M, Kinch D, Butt R, Gunstensen J, Saerens E, Genton E (1984) Effect of suloctidil on platelet function in patients with shortened platelet survival time. Thromb Res 35: 397?406
  41. Vandamme D, Vankerckhoven G, Vercamst R, Soetewey F, Blaton V, Peeters H, Rosseneu M (1978) A simple screening method for plasma lipids by thin-layer chromatography with flame ionization detection. Clin Chim Acta 89: 231?238
  42. Verhaeghe R, Van Hoof A, Beyens C (1981) Controlled trial of suloctidil 1 intermittent claudication. J Cardiovasc Pharmacol 3: 279?286
  43. Weibel ER, Stäubli W, Gnägi HR, Hess FA (1969) Correlated morphometric and biochemical studies on the liver cell. I. Morphometric model, stereologic model and normal morphometric data for rat liver. J Cell Biol 42: 68?91
  44. Wicksell SD (1925) The corpuscule problem. A mathematical study of a biometric problem. Biometrika 17: 84?99
  45. Witiak DT, Newman HA, Feller DR (eds) (1977) Clofibrate and related analogs: a comprehensive review. Medicinal research series, Marcel Dekker Inc., NY.
  46. Winand Jacques, Dehaye Jean-Paul, Hebbelinck Marcel, Christophe Jean, Antilipolytic action of suloctidil in rat adipose tissue, 10.1016/0006-2952(77)90369-0